S2040 Risk Factors for Hospital and ICU Admission in Patients Delisted for Liver Transplant

Kai-Lou Yue,Katherine Cooper,Dhruval Amin,Daniel Belza,Neil Marya,Navine Nasser-Ghodsi
DOI: https://doi.org/10.14309/01.ajg.0001037528.06574.1f
2024-10-26
The American Journal of Gastroenterology
Abstract:Liver transplant (LT) is the only curative treatment for end stage liver disease (ESLD). Patients awaiting LT are often critically ill requiring frequent hospitalizations and invasive interventions. Patients with ESLD who are not approved for LT have a high rate of short-term mortality with a median survival of 1.5-2 years. We aimed to characterize risk factors for hospital and intensive care (ICU) admissions in ESLD patients delisted for LT.
gastroenterology & hepatology
What problem does this paper attempt to address?